Medical / Pharmaceuticals News and Press Releases

Medical / Pharmaceuticals

Releases published in the last 30 days.

Page 2 of 2

Exhale Wellness Earns Top Ranking Among Delta 8 Brands by Arizona Digital Free Press: 5/22/2025 1:03:36 PM; Exhale Wellness has ranked first in the Arizona Digital Free Press’ latest list of the “Best Delta 8 Brands of 2025.” The ranking, released this week, evaluates leading cannabis and plant-based wellness companies based on product consistency, consumer satisfaction, regulatory adherence, and supply chain transparency.
Exhale Wellness Recognized as Top #1. THCA Flower Vendor by Arizona Digital Free Press: 5/22/2025 1:03:13 PM; Exhale Wellness, a hemp-derived cannabis brand based in Los Angeles, has been named the number one THCA flower vendor by Arizona Digital Free Press, an independent digital publication covering consumer health and lifestyle trends.
Johnson & Johnson to Participate in the Bernstein’s 41st Annual Strategic Decisions Conference: 5/22/2025 8:01:02 AM; UPDATED – Johnson & Johnson (NYSE: JNJ) will present at the Bernstein’s 41st Annual Strategic Decisions Conference on Wednesday, May 28th, 2025.
Study Links Residual Inflammation in Psoriasis Patients to Obesity and Fatty Liver Disease: 5/21/2025 11:28:53 AM; New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, inflammation can linger, leading to broader health implications such as obesity and cardiovascular and fatty liver disease.
$4.4 Billion U.S. Autism Treatment Market Still Growing: 5/20/2025 10:37:06 AM; May 20, 2025 - Marketdata LLC, a leading market research firm specializing in service and healthcare markets, has published an analysis of U.S. autism treatment centers and programs.
Birdeye Launches Brand AI and Industry AI: 5/20/2025 8:00:00 AM; Birdeye, the #1 platform for Hyperlocal Marketing, today announced the launch of Brand AI and Industry AI, two groundbreaking innovations in its BirdAI architecture.
Health Unchained Podcast Spotlights New Coalition for Decentralized Health and Life Sciences (CDHLS): 5/19/2025 8:30:00 AM; The Health Unchained podcast, hosted by Ray Dogum, has released a powerful new episode (#128) exploring one of the most transformative initiatives shaping decentralized healthcare: the Coalition for Decentralized Healthcare and Life Sciences (CDHLS).
Statement on the antigen composition of COVID-19 vaccines: 5/15/2025 8:59:23 AM; Key points • Vaccination remains an important public health countermeasure against COVID-19. As per the WHO Director General’s standing recommendations for COVID-19, Member States are recommended to continue to offer COVID-19 vaccination based on the recommendations of the WHO Strategic Advisory Group of Experts on Immunization (SAGE).
Axsome Therapeutics Enters $570 Million Term Loan and Revolving Credit Facility with Blackstone: 5/15/2025 7:33:41 AM; Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has entered into a $570 million term loan and revolving credit facility with funds managed by Blackstone Life Sciences and Blackstone Credit & Insurance (“Blackstone”).
Reshaping bone repair with 3D printing: 5/14/2025 5:12:49 AM; What if surgeons could replace damaged bone with a solution tailor-made to each patient? That’s the question researchers at the University of Waterloo are seeking to answer as they develop a material that mimics the behaviour of human bone and is capable of being 3D printed with a high degree of accuracy. Identifying a solution Lead researcher Dr.
Study shows vision-language models can’t handle queries with negation words: 5/14/2025 3:06:05 AM; Imagine a radiologist examining a chest X-ray from a new patient. She notices the patient has swelling in the tissue but does not have an enlarged heart.
Do bevacizumab’s ovarian cancer clinical trial results hold up in the real world?: 5/13/2025 5:14:27 PM; A real-world study based on information from an electronic health records–derived database reveals limited benefits of adding bevacizumab to first-line chemotherapy for patients with ovarian cancer, consistent with previous clinical trials.
New Study Reveals Our Skin’s Own Bacteria Can Help Protect Us From the Bad Effects of Sunlight: 5/13/2025 5:06:11 PM; The skin microbiome plays an important role in health and disease. Researchers have now substantiated that certain skin bacteria can protect us from the sun’s ultraviolet (UV) radiation specifically by metabolizing cis -urocanic acid using an enzyme called urocanase.
AMA names Dr. John Whyte next CEO/EVP: 5/12/2025 8:43:26 AM; CHICAGO – The American Medical Association (AMA) named John J. Whyte, M.D., M.P.H., as its next chief executive officer and executive vice president.